Jul 04, 2024
Berlin [Germany], July 4: German biotech firm CureVac said on Wednesday that it is selling the rights to its mRNA influenza and COVID-19 vaccines to British pharmaceutical group GSK for up to 1.45 billion euros (1.56 billion U.S. dollars) as part of a group restructuring.
Read More...
Jul 04, 2024
Geneva [Switzerland], July 4: The rise of populist politicians in Europe and other regions of the world...
Jul 04, 2024
Sofia [Bulgaria], July 4: Bulgaria's long stretch of political instability is set to continue after parliament voted...
Jul 04, 2024
Riga [Latvia], July 4: Lithuania plans to withdraw from the international convention banning the use of cluster...
Jul 04, 2024
Jul 04, 2024
Jul 03, 2024
Jul 03, 2024
Jul 03, 2024
Jul 03, 2024
Jul 03, 2024
Jul 03, 2024
